Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» CRISPR Therapeutics
CRISPR Therapeutics
FDA awarded record number of review designations to CRISPR drugs in 2023
Biopharma Reporter
Tue, 02/6/24 - 09:16 am
CRISPR
FDA
gene editing
CRISPR Therapeutics
Vertex Pharmaceuticals
Where Will CRISPR Therapeutics Be in 5 Years?
Motley Fool
Wed, 01/24/24 - 10:54 am
CRISPR Therapeutics
gene editing
CRISPR
What’s Next for CRISPR?
BioSpace
Tue, 01/23/24 - 06:00 pm
CRISPR
gene editing
Vertex Pharmaceuticals
CRISPR Therapeutics
Could Editas Medicine Become the Next CRISPR Therapeutics?
Motley Fool
Sun, 01/21/24 - 05:01 pm
Editas Medicine
gene editing
CRISPR Therapeutics
FDA widens approval of Vertex’s CRISPR medicine to treat beta thalassemia
BioPharma Dive
Wed, 01/17/24 - 09:34 am
Vertex Pharmaceuticals
CRISPR Therapeutics
Casgevy
beta thalassemia
FDA
Trials to watch: CRISPR pipeline accelerates after milestone Casgevy approval
Clinical Trials Arena
Wed, 01/17/24 - 09:30 am
CRISPR
gene editing
clinical trials
Casgevy
Vertex Pharmaceuticals
CRISPR Therapeutics
EdiGene
Shanghai Vitalgen BioPharma
Regeneron
Vor Biopharma
5 FDA Decisions to Watch in Q1
BioSpace
Tue, 01/2/24 - 11:24 am
FDA
Iovance Biotherapeutics
melanoma
lifileucel
Minerva Neurosciences
schizophrenia
roluperidone
Viatris
Mapi Pharma
MS
multiple sclerosis
GA Depot
Madrigal Pharmaceuticals
NASH
resmetirom
Vertex Pharmaceuticals
CRISPR Therapeutics
exa-cel
beta thalassemia
CRISPR eyes autoimmune disease in revamp of cell therapy plans
BioPharma Dive
Tue, 12/5/23 - 11:38 am
CRISPR Therapeutics
cell therapy
autoimmune disease
cancer
What to know about the U.K.’s approval of the first CRISPR treatment for diseases
Nature
Fri, 11/17/23 - 10:05 am
UK
CRISPR
gene editing
Casgevy
Vertex Pharmaceuticals
CRISPR Therapeutics
Vertex, CRISPR Win World’s First Approval for CRISPR-Edited Therapy from UK
BioSpace
Thu, 11/16/23 - 10:21 am
CRISPR
gene editing
Vertex Pharmaceuticals
CRISPR Therapeutics
UK
Casgevy
beta thalassemia
Cell & Gene Therapy Space Gears Up for First CRISPR Approval
BioSpace
Mon, 11/13/23 - 11:48 am
CRISPR
gene therapy
cell therapy
sickle cell disease
exa-cel
Vertex Pharmaceuticals
CRISPR Therapeutics
Two Sickle Cell Disease Gene Therapies May Soon Be Approved By FDA
Forbes
Thu, 11/2/23 - 05:07 pm
sickle cell disease
gene therapy
lovo-cel
exa-cel
Vertex Pharmaceutical
CRISPR Therapeutics
Bluebird Bio
FDA panel says Vertex/CRISPR to assess safety risks of gene therapy in follow-up study
Yahoo/Reuters
Tue, 10/31/23 - 09:23 pm
Vertex Pharmaceuticals
CRISPR Therapeutics
FDA
gene therapy
exa-cel
5 FDA decisions to watch in the fourth quarter
BioPharma Dive
Mon, 10/2/23 - 12:00 pm
FDA
Alnylam
Onpattro
ATTR amyloidosis
Vertex Pharmaceuticals
CRISPR Therapeutics
exa-cel
Bluebird Bio
Zynteglo
sickle cell disease
Bristol Myers Squibb
2seventy bio
Abecma
Multiple Myeloma
Amgen
Lumakras
non-small cell lung cancer
Pfizer
estrasimod
ulcerative colitis
This 1 Innovation Could Make These 2 Biotechs Soar by 2030
Motley Fool
Sun, 07/23/23 - 12:28 pm
cell therapy
Caribou Biosciences
CRISPR Therapeutics
U.S. watchdog lifts price estimate for Bluebird, Vertex/CRISPR gene therapies to $2.1 million
Reuters
Fri, 07/14/23 - 10:07 am
ICER
gene therapy
Vertex Pharmaceuticals
CRISPR Therapeutics
Bluebird Bio
drug pricing
sickle cell disease
9 Highly Anticipated FDA Decisions in Second Half of 2023
BioSpace
Fri, 06/30/23 - 11:52 am
FDA
Eisai
Biogen
Leqembi
Alzheimer's disease
SAGE Therapeutics
zuranolone
postpartum depression
major depressive disorder
Roche
Tecentriq
non-small cell lung cancer
CRISPR Therapeutics
Bluebird Bio
lovo-cel
exa-cel
BrainStorm Cell Therapeutics
NurOwn
Gene Editing Race Between Editas and Vertex, CRISPR Heats Up
BioSpace
Mon, 06/12/23 - 09:58 am
gene editing
Editas Medicine
Vertex Pharmaceuticals
CRISPR Therapeutics
EDIT-301
sickle cell disease
beta thalassemia
Landmark approval for Vertex's CRISPR drug 2 steps closer after trial wins, PDUFA date granted
Fierce Biotech
Fri, 06/9/23 - 10:07 am
Vertex Pharmaceuticals
CRISPR Therapeutics
CRISPR
gene editing
FDA
sickle cell disease
beta thalassemia
2023’s biggest launches: the story so far
EP Vantage
Fri, 05/12/23 - 10:19 am
drug launches
AbbVie
Almirall
Apellis Pharmaceuticals
Astellas
AstraZeneca
Biogen
CRISPR Therapeutics
Daiichi Sankyo
Eli Lilly
Genmab
GSK
Iveric Bio
Pfizer
Roche
SAGE Therapeutics
Sanofi
Sarepta Therapeutics
Shionogi
Swedish Orphan Biovitrum
Vertex Pharmaceuticals
Pages
1
2
3
4
5
next ›
last »